Loading…
MetLife, Inc. is projected to rise to $101.26 by 2027, a +22% move from its current price of $83.20. MET is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $82.32 | $83.19 | $84.07 | -0.02% |
| May 30 | $81.95 | $83.17 | $84.42 | -0.03% |
| May 31 | $81.66 | $83.16 | $84.69 | -0.05% |
| Jun 1 | $81.42 | $83.15 | $84.92 | -0.06% |
| Jun 2 | $81.20 | $83.14 | $85.12 | -0.08% |
| Jun 3 | $81.01 | $83.12 | $85.30 | -0.09% |
| Jun 4 | $80.83 | $83.11 | $85.46 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $80.83 | $83.11 | $85.46 | -0.11% |
| Week 2 | $79.82 | $83.03 | $86.36 | -0.21% |
| Week 3 | $79.03 | $82.94 | $87.04 | -0.32% |
| Week 4 | $78.36 | $82.85 | $87.60 | -0.42% |
| Week 5 | $77.77 | $82.76 | $88.08 | -0.52% |
| Week 6 | $77.22 | $82.68 | $88.51 | -0.63% |
| Week 7 | $76.72 | $82.59 | $88.90 | -0.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MetLife, Inc. is a financial services company that provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings.
The company offers a broad range of products and services, including life, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products, among other offerings. The company was incorporated in 1999 and is based in New York, New York.
MetLife, Inc. (MET) is a financial services company with a current price of $84.06 and a market capitalization of $54.09B, ranking 296. The stock sits between key moving averages with a bullish longer-term outlook suggested by the year-by-year forecast.
The forecast shows notable upside, with the average price rising from $84.06 in 2026 to $162.37 by 2030, and further to $362.20 by 2040 and $815.81 by 2050, accompanied by increasingly positive ROIs (e.g., 93.2% in 2030, 330.9% in 2040, and 870.5% in 2050).
Specific forecast values indicate a path higher through the coming years, with the 2026 average at $84.06 and progressive gains projected in later years. The forecast also presents a broad range for each year, highlighting potential upside and volatility inherent in equities over multi-year horizons.
A major floor 18.6% below — a decisive break under it would weaken the trend.
The nearest floor, 8.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 7.5% above — clearing it would confirm fresh momentum.
Key MET support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MET market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $83.47 | Sell | $83.02 | Buy |
| MA 10 | $81.69 | Buy | $82.06 | Buy |
| MA 20 | $80.43 | Buy | $80.56 | Buy |
| MA 50 | $76.05 | Buy | $77.99 | Buy |
| MA 100 | $76.09 | Buy | $77.10 | Buy |
| MA 200 | $77.73 | Buy | $77.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.94 | Neutral |
| Stoch RSI (14) | 64.80 | Neutral |
| CCI (20) | 109.88 | Buy |
| Williams %R (14) | -17.41 | Info |
| MACD (12,26,9) | 0.24 | Buy |
| ROC (12) | 6.56 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 82.59 | Sell |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 4.55 | Buy |
| Ultimate (7,14,28) | 71.39 | Sell |
| Momentum (10) | 4.56 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 84.48 | Sell |
| ADX (14) | 29.17 | Buy |
| ATR (14) | 0.79 | Info |
The 30-day technical picture is bullish. RSI14 is 70, and the stock trades above both the 50-day and 200-day moving averages (SMA50 is $75.46 and SMA200 is $77.65), suggesting positive momentum.
Support is at $75.36 and resistance at $84.30, framing a near-term trading range. The 30-day price range runs from $78.18 to $90.38, indicating potential upside within a defined band before a clearer breakout or pullback occurs.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $67.70 | $83.20 | $107.78 | 0% | Neutral | |
| $82.72 | $101.26 | $129.75 | +22% | Bullish | |
| $92.25 | $114.99 | $151.18 | +38% | Bullish | |
| $112.95 | $142.91 | $191.81 | +72% | Bullish | |
| $123.45 | $158.28 | $216.19 | +90% | Bullish | |
| $127.64 | $165.64 | $229.77 | +99% | Bullish | |
| $139.81 | $183.45 | $258.06 | +121% | Bullish | |
| $142.40 | $188.82 | $269.00 | +127% | Bullish | |
| $159.53 | $213.61 | $307.93 | +157% | Bullish | |
| $193.48 | $261.51 | $381.14 | +214% | Bullish | |
| $245.69 | $346.29 | $528.76 | +316% | Bullish | |
| $513.55 | $776.19 | $1,270.06 | +833% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $67.70 | $83.20 | $97.59 | +0.00% |
| June 2026 | $71.52 | $83.43 | $99.21 | +0.27% |
| July 2026 | $69.95 | $82.07 | $98.52 | -1.63% |
| August 2026 | $70.74 | $83.38 | $100.82 | +1.60% |
| September 2026 | $71.86 | $85.00 | $103.39 | +1.95% |
| October 2026 | $70.97 | $84.24 | $103.02 | -0.89% |
| November 2026 | $71.01 | $84.53 | $103.87 | +0.35% |
| December 2026 | $73.14 | $87.33 | $107.78 | +3.30% |
Click any year to see its month-by-month MET forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MET price prediction for 2026 points to an average of $83.20 (low $67.70, high $107.78) — a potential gain of 0% on today's $83.20. A consolidation phase looks the most probable path here.
In 2027, MET is projected to trade between $82.72 and $129.75, averaging $101.26 — a potential gain of +22% from today's $83.20. That is up +22% on the projected 2026 average. Momentum favours further upside here.
MetLife, Inc.'s 2028 outlook centres on $114.99, within a $92.25 to $151.18 range. That is up +14% on the projected 2027 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, MET could reach as high as $191.81, with a base case around $142.91 and support toward $112.95 — roughly +72% from $83.20. Momentum favours further upside here.
Expect MET to range from $123.45 to $216.19 through 2030. The $158.28 average target implies a +90% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MET price prediction for 2031 points to an average of $165.64 (low $127.64, high $229.77) — a potential gain of +99% on today's $83.20. Momentum favours further upside here.
In 2032, MET is projected to trade between $139.81 and $258.06, averaging $183.45 — a potential gain of +121% from today's $83.20. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
MetLife, Inc.'s 2033 outlook centres on $188.82, within a $142.40 to $269.00 range. That is up +3% on the projected 2032 average. That marks a +127% change versus current levels. Momentum favours further upside here.
By 2034, MET could reach as high as $307.93, with a base case around $213.61 and support toward $159.53 — roughly +157% from $83.20. Buyers look set to stay in control over this stretch.
Expect MET to range from $193.48 to $381.14 through 2035. The $261.51 average target implies a +214% move from current prices. That is up +22% on the projected 2034 average. Momentum favours further upside here.
The MET price prediction for 2040 points to an average of $346.29 (low $245.69, high $528.76) — a potential gain of +316% on today's $83.20. Buyers look set to stay in control over this stretch.
In 2050, MET is projected to trade between $513.55 and $1,270.06, averaging $776.19 — a potential gain of +833% from today's $83.20. That is up +124% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MET today (≈ 12.019231 MET) could be worth
$9,329.25
+$8,329.25 (+833%) by 2050 · US Dollar
Based on the average projected MET price of $776.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in METwould be worth at today's price.
$1,000 invested in MET on May 27, 2025 (≈ 12.653423 MET) would be worth
$1,052.76
+$52.76 (+5.3%) today · 1.05× · US Dollar
Based on a MET entry price of $79.03 vs. today's $83.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $82.51 | $1,008.36 | +0.8% |
| 1 month ago | $77.67 | $1,071.2 | +7.1% |
| 3 months ago | $75.94 | $1,095.6 | +9.6% |
| 6 months ago | $76.56 | $1,086.73 | +8.7% |
| 1 year ago | $79.03 | $1,052.76 | +5.3% |
| All time (5.0y) ago | $66.51 | $1,250.94 | +25.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MET forecast.
Our base-case forecast reaches $170.00 around 2032.
Implied market cap at $170.00: $109.38B
The multi-year forecast depicts meaningful upside with a bullish tilt for 2030, 2040, and 2050. In 2030, the forecast lists a min of $126.61, an avg of $162.37, a max of $221.82, and a ROI of 93.2%.
For 2040, the min is $256.95, the avg is $362.20, the max is $553.11, and the ROI is 330.9%, with a bullish sentiment attached. In 2050, the min reaches $539.72, the avg rises to $815.81, the max to $1,334.99, and the ROI climbs to 870.5%, also with a bullish sentiment.
These figures are estimates and not guaranteed; actual results may differ. The forecast reflects upside potential over the long term, but there is inherent downside risk and uncertainty in any projection.
Tap a question to reveal the answer.
2030 forecast: avg $162.37, min $126.61, max $221.82 with ROI 93.2% and sentiment BULLISH.
The long-term outlook is bullish with substantial upside–avg prices rise into the hundreds by 2030 and beyond, and ROIs reach the 90s to 800+ percent by 2050. These are estimates and not guarantees.
Yes. The 2050 max forecast is $1,334.99, which is above $1,000.
The current price is $84.06.
2040 forecast: avg $362.20, min $256.95, max $553.11 with ROI 330.9% and sentiment BULLISH.
MetLife, Inc. Community Discussion
0Share your MetLife, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.